α-Glucosidase-IN-32
α-Glucosidase-IN-32 (compound f26) is a reversible, noncompetitive and orally active α-glucosidase inhibitor with an IC50 value of 3.07 μM. α-Glucosidase-IN-32 complex with α-glucosidase through hydrogen bonds and hydrophobic interactions, led to changes in the conformation and secondary strictures of α-glucosidase and further the inhibition of the enzymatic activity. α-Glucosidase-IN-32 can be used for diabetic disease research[1].
Product Specifications
UNSPSC
12352005
Target
Glycosidase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/α-glucosidase-in-32.html
Solubility
10 mM in DMSO
Smiles
C1(C2=NC(C3=NN=C(SCC4=CC=CC=C4C5=CC=CC=C5)O3)=CC6=C2NC7=CC=CC=C67)=CC=CC=C1
Molecular Formula
C32H22N4OS
Molecular Weight
510.61
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Chromogranin A / CHGA (Neuroendocrine Marker) (rCHGA/798), CF594 conjugate, 0.1mg/mL
Decorin (DCN) (NM_001920) Human Over-expression Lysate
Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), CF640R conjugate, 0.1mg/mL
